Press releases
- Sangamo Therapeutics Reports on Pfizer’s Announcement of Positive Topline Results From Phase 3 Trial of Hemophilia A Gene Therapy Candidate
- Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
- Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing
- Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
Key statistics
As of last trade Sangamo Therapeutics Inc (GBY:BRN) traded at 0.424, 0.71% above its 52-week low of 0.421, set on Jul 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.421 |
---|---|
High | 0.424 |
Low | 0.421 |
Bid | 0.399 |
Offer | 0.403 |
Previous close | 0.424 |
Average volume | 5.00k |
---|---|
Shares outstanding | 207.51m |
Free float | 191.47m |
P/E (TTM) | -- |
Market cap | 83.27m USD |
EPS (TTM) | -1.86 USD |
Data delayed at least 15 minutes, as of Jul 12 2024.
More ▼